Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05741723

OCS DCD Heart + CAP Continued Follow-Up

The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of California San Diago, La Jolla, California, United States

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients transplanted in the OCS DCD Heart Trial and OCS DCD Heart CAP trials.

Treatment and study plan

OCS Heart

Device

Transplanted with OCS preserved heart.

Primary outcomes

  1. Patient survival

    Time frame: 5 years post-transplant

    Patient survival through 5 years post-transplant

Other outcomes

  1. Cardiac related patient survival

    Time frame: 5 years post-transplant

    Cardiac related patient survival through 5 years post-transplant

  2. Graft survival

    Time frame: 5 years post-transplant

    Graft survival through 5 years post-transplant

  3. Patient and graft survival

    Time frame: 5 years post-transplant

    Patient and graft survival through 5 years post-transplant

Sponsors and collaborators

Lead sponsor

TransMedics

Industry

Registry information

Official study title

OCS DCD Heart + CAP Continued Follow-Up Post-Approval Study

Important dates

Study start
2019
Primary completion
2026
Study completion
2026
First posted
Feb 23, 2023
Registry last updated
Sep 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.